first
step
tissu
cultur
date
back
begin
nineteenth
centuri
biosafeti
measur
yet
exist
later
anim
cell
cultur
becam
essenti
scientif
research
diagnosi
biotechnolog
activ
along
develop
biosafeti
concern
emerg
point
risk
human
health
lesser
extent
environ
associ
handl
anim
cell
cultur
manag
risk
requir
thorough
risk
assess
cell
cultur
type
manipul
prior
start
activ
involv
casebycas
evalu
intrins
properti
cell
cultur
genet
modifi
probabl
may
inadvert
intent
becom
infect
pathogen
microorgan
latter
hazard
predomin
adventiti
contamin
pathogen
better
capac
persist
unfavour
condit
consequ
contain
measur
primarili
aim
protect
cell
adventiti
contamin
cell
cultur
known
harbour
infecti
etiolog
agent
manipul
complianc
contain
measur
recommend
etiolog
agent
manipul
cell
cultur
human
primat
origin
necessit
use
type
ii
biosafeti
cabinet
scope
chapter
highlight
aspect
relev
risk
assess
summar
main
biosafeti
recommend
recent
technolog
advanc
allow
mitig
risk
handl
anim
cell
cultur
specifiedpathogenfre
tse
transmiss
spongiform
encephalopathi
biosafeti
concept
refer
need
protect
human
health
environ
possibl
advers
effect
pathogen
andor
genet
modifi
organ
microorgan
use
basic
research
research
develop
r
modern
biotechnolog
end
casebycas
risk
assess
conduct
consist
identif
characteris
potenti
effect
may
intend
unintend
togeth
assess
likelihood
consequ
effect
occur
depend
risk
identifi
risk
manag
measur
propos
use
cell
cultur
may
fall
within
scope
one
sever
regulatori
provis
consid
assess
biolog
risk
exampl
europ
tissu
cultur
work
mani
case
involv
use
genet
modifi
cell
line
well
case
risk
assess
made
accord
provis
direct
relat
contain
use
genet
modifi
microorgan
european
commiss
cell
cultur
activ
aim
manufactur
biopharmaceut
cover
regul
ec
amend
act
lay
procedur
authoris
supervis
medicin
product
human
veterinari
use
european
commiss
wherea
activ
involv
use
human
cell
tissu
applic
human
bodi
fall
within
scope
direct
amend
act
european
commiss
manipul
anim
cell
cultur
also
expos
worker
potenti
biolog
risk
consid
provis
european
direct
ec
european
commiss
point
guidelin
aim
mitig
biolog
risk
laboratori
worker
public
health
environ
issu
scientif
advisori
bodi
compet
author
world
health
organ
center
diseas
control
prevent
swiss
expert
committe
biosafeti
biosafeti
recommend
outlin
hereaft
princip
aim
provid
maxim
protect
human
health
includ
laboratori
worker
environ
recognis
mani
precautionari
measur
also
directli
benefit
qualiti
research
activ
involv
anim
cell
cultur
inde
crosscontamin
lucey
et
al
capesdavi
et
al
et
al
et
al
johnen
et
al
macleod
et
al
inadvert
contamin
infecti
microorgan
bacteria
fungi
yeast
viru
prion
plagu
mani
research
often
lead
unproduct
data
misinterpret
result
consider
wast
time
energi
mahi
et
al
drexler
uphoff
mirjalili
et
al
cobo
et
al
pinheiro
de
oliveira
et
al
also
emphas
even
good
manufactur
process
gmp
aim
protect
product
gmp
measur
compat
biosafeti
measur
reveal
complementari
object
chapter
address
review
biorisk
assess
manag
consider
diagnost
research
activ
involv
cell
cultur
histor
perspect
assess
biolog
risk
empir
basi
result
awar
scientif
commun
regard
risk
associ
handl
pathogen
organ
demonstr
mani
report
case
laboratoryacquir
infect
follow
potenti
risk
associ
experi
involv
recombin
dna
initi
implement
measur
guarante
safe
use
recombin
dna
link
safeti
measur
time
alreadi
success
appli
microbiolog
contain
pathogen
organ
nation
institut
health
conjunct
two
aspect
constitut
two
pillar
biosafeti
led
classif
system
organ
risk
class
risk
group
far
mani
risk
assess
carri
among
scientif
commun
use
pathogen
organ
genet
modifi
regardless
scale
purpos
activ
basi
risk
assess
methodolog
take
account
recent
scientif
technic
data
use
scientif
sound
approach
methodolog
biolog
risk
assess
contain
use
activ
involv
pathogen
andor
genet
modifi
organ
gmo
identifi
take
account
probabl
occurr
sever
potenti
neg
effect
public
health
includ
expos
worker
andor
environ
result
methodolog
well
characteris
risk
lead
choic
appropri
prevent
measur
encompass
adopt
appropri
contain
level
use
safeti
equip
includ
person
protect
equip
work
practic
wast
manag
risk
assess
methodolog
commonli
use
approach
describ
fig
first
step
take
account
characterist
organ
use
case
genet
modif
genet
materi
introduc
result
gmo
base
inform
rel
harm
characterist
natur
pathogen
microorgan
categoris
sever
class
risk
risk
group
classif
take
account
sever
diseas
pathogen
organ
may
caus
human
anim
health
abil
spread
amongst
popul
avail
prophylaxi
effici
treatment
world
health
organ
zoopathogen
classif
system
mainli
base
definit
world
organis
anim
health
oie
categoris
anim
pathogen
four
group
accord
risk
anim
health
sinc
risk
human
health
well
world
organis
anim
health
microorgan
unlik
caus
diseas
classifi
class
risk
etiolog
agent
respons
sever
diseas
high
potenti
transmiss
prophylaxi
treatment
avail
assign
class
risk
pathogen
organ
categoris
class
risk
class
risk
period
revis
refer
list
issu
intern
nation
author
advisori
committe
classifi
natur
biolog
agent
genet
modifi
risk
group
assign
biosafeti
level
manipul
second
step
magnitud
identifi
neg
effect
human
diseas
includ
allergen
toxic
effect
transfer
genet
materi
organ
character
third
step
assess
perform
exposur
laboratori
worker
popul
andor
environ
consid
organ
consequ
neg
effect
occur
fourth
step
character
risk
perform
result
assign
risk
level
associ
contain
use
involv
use
organ
basi
contain
measur
protect
measur
eg
safe
work
practic
safeti
equip
biolog
wast
manag
adopt
determin
four
level
fig
flow
diagram
summar
biorisk
assess
manag
methodolog
risk
contain
use
assign
level
risk
increas
final
step
consist
definit
classifi
contain
use
activ
conduct
reassess
whole
procedur
start
research
diagnosi
product
activ
chapter
risk
assess
methodolog
appli
anim
cell
cultur
develop
illustr
exampl
import
mention
risk
assess
alway
perform
case
case
basi
scientist
respons
activ
biosafeti
offic
biosafeti
profession
complianc
local
guidanc
regulatori
requir
risk
assess
appli
anim
cell
cultur
reli
thorough
evalu
intrins
properti
cell
cultur
includ
subsequ
properti
acquir
result
genet
modif
possibl
cell
cultur
may
inadvert
contamin
deliber
infect
pathogen
microorgan
also
includ
exposur
assess
mean
type
manipul
carri
cell
cultur
taken
account
assess
cell
cultur
harbour
pathogen
follow
principl
assess
pathogen
first
main
organ
characterist
comprehens
descript
pathogen
consid
take
account
follow
paramet
order
import
pathogen
avail
infecti
dose
mode
transmiss
host
rang
epidemiolog
assign
appropri
risk
group
may
depend
geograph
localis
possibl
reservoir
vector
abil
zoonosi
stabil
persist
organ
environ
ie
surviv
outsid
host
addit
inform
relat
physicochem
properti
pathogen
organ
consid
suscept
disinfect
physic
inactiv
drug
suscept
eg
sensit
known
resist
antibiot
antivir
compound
final
aspect
relat
diseas
caus
pathogen
also
taken
consider
includ
avail
effect
prophylaxi
avail
effici
therapi
report
case
laboratoryacquir
infect
lai
although
underestim
mani
case
lai
relat
handl
cell
cultur
andor
contain
viru
suspens
report
among
report
laboratori
worker
exposur
recombin
vaccinia
virus
amplifi
cell
cultur
result
infect
openshaw
et
al
mempel
et
al
et
al
wlodav
et
al
lewi
et
al
center
diseas
control
prevent
recommend
work
safe
vaccinia
viru
review
recent
togeth
overview
report
case
lai
involv
viru
isaac
risk
assess
cell
cultur
genet
modifi
basic
follow
compar
approach
characterist
gmo
compar
nonmodifi
wildtyp
organ
deriv
correspond
situat
use
distinct
featur
risk
assess
genet
modifi
cell
cultur
consist
evalu
recipi
cell
vector
donor
organ
insert
genet
materi
insert
develop
sect
good
knowledg
characteris
intrins
properti
cell
key
success
safe
cell
cultur
respect
biolog
risk
risk
assess
associ
manipul
anim
cell
cultur
three
properti
intrins
cell
cultur
consid
speci
origin
cell
type
type
tissu
organ
cell
line
deriv
statu
cultur
fig
respect
speci
origin
base
fact
pathogen
usual
specif
speci
barrier
consid
closer
genet
relationship
cell
cultur
human
higher
risk
human
incid
harbour
organ
could
caus
harm
human
health
therefor
consid
higher
human
primat
cell
compar
cell
nonhuman
origin
brown
accordingli
mammalian
cell
human
primat
cell
consid
repres
less
risk
follow
avian
invertebr
cell
howev
kept
mind
infecti
agent
abl
cross
speci
barrier
persist
new
host
speci
lead
zoonot
diseas
acknowledg
sinc
mani
year
less
emerg
infecti
diseas
zoonot
chomel
et
al
well
document
case
virus
cross
speci
barrier
anim
reservoir
human
includ
hantaviru
murin
reservoir
haemorrhag
fever
virus
ebola
marburg
peter
et
al
avian
influenza
viru
reper
et
al
sever
acut
respiratori
syndrom
sar
associ
coronaviru
ksiazek
et
al
herman
et
al
exampl
show
incid
crossspeci
transfer
occur
occup
risk
relat
exposur
infect
anim
tissu
cell
cultur
underestim
mahi
brown
louz
et
al
cell
may
dramat
differ
vivo
halflif
depend
cell
type
type
tissu
deriv
exampl
intestin
certain
leukocyt
halflif
day
human
erythrocyt
approxim
halflif
healthi
liver
cell
life
span
sever
month
wherea
adult
slow
loss
brain
cell
littl
replac
partli
due
fact
cell
line
readili
obtain
other
establish
cell
line
often
obtain
seri
gener
uncontrol
mutat
occur
cultur
cell
longer
period
known
cell
cultur
extens
period
time
display
chang
growth
properti
reduct
doubl
time
result
transform
may
give
cell
abil
overgrow
rest
popul
surviv
larg
infinit
number
passag
compar
primari
cell
finit
life
span
therefor
establish
cell
cultur
certain
cell
type
upon
extens
passag
reli
posit
select
cell
growth
advantag
transform
cell
increas
tumorigen
potenti
may
present
risk
becomingb
fulli
neoplast
upon
accident
gugel
sander
deliber
introduct
human
bodi
therefor
take
tumorigen
potenti
account
follow
cell
type
may
rank
increas
order
risk
epitheli
fibroblast
cell
gut
mucosa
endothelium
neural
tissu
haematogen
eg
blood
lymphoid
cell
tissu
third
inher
properti
consid
statu
cell
cultur
diagnost
research
activ
involv
manipul
primari
cultur
cell
line
well
continu
cell
line
deriv
primari
cultur
primari
cell
cultur
cell
strain
produc
directli
organ
tissu
often
accur
vitro
tool
reproduc
typic
cellular
respons
observ
vivo
howev
characteris
finit
life
span
time
avail
characteris
detect
contamin
agent
remain
limit
also
typic
cell
characterist
often
lost
passag
cell
primari
cell
cultur
repeatedli
obtain
fresh
tissu
result
increas
risk
potenti
contamin
pathogen
featur
distinguish
continu
cell
line
primari
cell
cultur
abil
surviv
infinit
least
great
number
passag
immortalis
cell
obtain
isol
cell
tumour
mutat
primari
cell
mutagen
use
virus
recombin
dna
gener
indefinit
grow
cell
cell
fusion
primari
cell
continu
cell
line
due
increas
life
span
time
left
thorough
characteris
detect
contamin
agent
consider
increas
within
respect
wellcharacteris
cell
line
present
lowest
risk
compar
primari
cultur
less
characteris
cell
line
origin
sourc
suitabl
wellknown
welldefin
cell
line
obtain
extern
sourc
eg
differ
laboratori
crosscontamin
celllin
andor
lack
proof
ident
actual
widespread
problem
buehr
et
al
capesdavi
et
al
order
least
evid
speci
origin
cell
line
abl
conduct
thorough
risk
assess
may
necessari
fulli
characteris
use
cell
line
purpos
number
techniqu
avail
cytogenet
analysi
dna
fingerprint
pcr
flow
cytometri
isoenzym
analysi
matsuo
et
al
cabrera
et
al
mani
microorgan
benefit
cell
machineri
complet
life
cycl
dissemin
henc
studi
pathogen
lifecycl
immun
escap
mechan
requir
intent
vitro
infect
anim
human
cell
identif
potenti
hazard
associ
infect
cell
cultur
requir
consider
intrins
cell
properti
inher
properti
infect
pathogen
latter
impli
assess
number
pathogen
specif
criteria
along
aspect
exist
effect
treatment
prophylaxi
basi
criteria
defin
classif
system
enabl
categoris
microorgan
four
risk
group
world
health
organ
fundament
rule
biolog
risk
infect
cell
cultur
depend
infect
pathogen
class
risk
exampl
cell
cultur
deliber
infect
hepat
c
viru
hcv
order
produc
viru
particl
assign
class
risk
hcv
class
risk
viru
human
cell
infect
airborn
pathogen
like
speci
mycobacterium
tuberculosi
complex
also
assign
class
risk
requir
adopt
biosafeti
level
contain
howev
discuss
class
risk
infect
cell
cultur
assign
necessarili
indic
level
contain
implement
latter
also
determin
natur
work
carri
cell
exampl
infect
bovin
leukocyt
theileria
parva
ticktransmit
intracellular
protozoan
veterinari
import
caus
agent
east
coast
fever
among
domest
livestock
anim
pathogen
risk
group
pathogen
human
sporozoit
form
infect
form
invad
bovin
lymphocyt
develop
noninfect
form
shizont
induc
host
cell
transform
clonal
expans
cell
infect
bovin
leucocyt
may
categoris
class
risk
anim
biosafeti
level
appropri
handl
determin
presenc
absenc
infecti
form
parasit
cell
cultur
also
coupl
electron
microscopi
identifi
viral
diseas
unknown
caus
shown
recent
studi
publish
center
diseas
control
prevent
goldsmith
et
al
case
outbreak
harvest
tissu
dead
live
infect
patient
inocul
permiss
cell
line
gener
vero
cell
eventu
subject
electron
microscopi
morpholog
analysi
causal
viru
although
altern
method
high
throughput
dna
sequenc
avail
identifi
microorgan
without
prior
vitro
expans
cell
cultur
follow
electron
microscopi
remain
complementari
approach
choic
molecular
method
unbias
diagnosi
illdefin
infecti
diseas
diagnost
activ
present
author
requir
adopt
measur
handl
cell
cultur
illustr
activ
involv
vitro
amplif
unknown
viru
may
repres
risk
laboratori
personnel
requir
adopt
appropri
contain
level
work
practic
adventiti
contamin
cell
cultur
major
drawback
activ
involv
cell
cultur
langdon
caus
agent
cell
contamin
includ
bacteria
fungi
mycoplasm
parasit
virus
prion
even
anim
cell
besid
fact
contamin
cell
cultur
may
place
experiment
result
question
may
lead
loss
cell
cultur
one
main
biosafeti
concern
manipul
anim
cell
cultur
research
diagnosi
product
purpos
fact
may
provid
support
contamin
agent
caus
harm
human
health
gener
bacteri
fungal
contamin
readili
detect
capac
overgrow
cell
cultur
typic
organ
caus
increas
turbid
ph
shift
media
chang
media
colour
slower
growth
cell
cell
destruct
antibiot
may
use
prevent
cell
bacteri
contamin
howev
continu
use
antibiot
cultur
may
lead
develop
resist
organ
slow
grow
properti
much
difficult
detect
direct
visual
observ
compar
bacteri
fungal
infect
mycoplasma
contamin
give
problem
term
incid
detect
prevent
erad
mycoplasma
intracellular
bacterium
one
common
cell
cultur
contamin
may
go
unnot
mani
passag
chang
sever
cell
properti
growth
metabol
morpholog
genom
structur
paddenberg
et
al
mcgarriti
kotani
also
report
influenc
yield
viru
product
infect
cell
hargreav
leach
mycoplasm
contamin
also
biosafeti
concern
contamin
mycoplasma
spp
belong
risk
group
togeth
arginini
oral
pirum
fermentan
pathogen
organ
like
gallisepticum
risk
group
anim
hyorhini
risk
group
anim
pneumonia
homini
risk
group
human
account
mycoplasma
contamin
cell
cultur
primari
sourc
contamin
oral
fermentan
homini
laboratori
infect
peopl
handl
cell
cultur
suspens
virus
sourc
argini
hyorhini
usual
anim
donor
tissu
biolog
constitu
use
cell
cultur
eg
calf
serum
trypsin
razin
tulli
pinheiro
de
oliveira
et
al
alreadi
report
contamin
cell
cultur
mycoplasma
occur
via
aerosol
oconnel
et
al
viral
contamin
merit
particular
attent
infect
cell
may
pose
seriou
harm
human
health
especi
infect
cell
abl
releas
infecti
particl
human
cell
may
infect
variou
virus
like
hepat
virus
retrovirus
herp
virus
papillomavirus
although
cell
cultur
nonhuman
origin
may
pose
less
risk
emphasis
mani
virus
broad
host
rang
cross
speci
barrier
sinc
number
nonhuman
virus
capabl
infect
andor
replic
human
cell
vitro
possibl
infect
human
cell
vivo
human
exposur
occur
care
consid
wellknown
viral
contamin
primat
tissu
cell
nonhuman
origin
caus
human
diseas
list
tabl
contamin
virus
may
associ
chang
cell
morpholog
behaviour
format
syncytia
hiv
herp
virus
swell
cell
adenovirus
haemagglutin
haemadsorpt
viral
contamin
may
harder
detect
cytopath
effect
remain
absent
viral
contamin
could
also
trigger
advers
effect
result
recombin
event
phenotyp
mix
contamin
compon
experiment
introduc
agent
creat
agent
new
properti
exampl
experiment
result
suggest
htlvi
htlvii
undergo
phenotyp
mix
coinfect
cell
lead
increas
pathogen
broaden
spectrum
cellular
tropism
neg
cell
lusso
et
al
anoth
exampl
contamin
murin
cell
cultur
lymphocyt
choriomening
viru
lcmv
lcmv
arenaviru
establish
silent
chronic
infect
mice
caus
asept
mening
enceph
meningoenceph
human
signific
lcmv
contamin
reinforc
descript
case
laboratoryacquir
lcmv
infect
aris
contamin
murin
tumour
cell
line
mahi
et
al
manipul
lcmv
infect
materi
materi
increas
likelihood
lcmv
contamin
necessit
whitley
papovavirus
butel
adventiti
contamin
parasit
may
issu
handl
primari
cell
organ
cultur
origin
donor
organ
known
suspect
infect
specif
parasit
life
cycl
parasit
compris
distinct
development
stage
transmiss
surviv
parasit
strongli
depend
abil
invas
stage
recogn
invad
specif
host
cell
even
cell
develop
noninfecti
form
parasit
possibl
harm
effect
remain
consid
sinc
natur
mode
transmiss
could
bypass
manipul
infect
cell
recognis
parasit
laboratori
acquir
infect
caus
needl
stick
injuri
herwaldt
final
use
bovinederiv
product
tissu
cultur
supplement
may
also
lead
contamin
unconvent
agent
caus
transmiss
spongiform
encephalopathi
tse
socal
prion
solassol
et
al
cronier
et
al
vorberg
et
al
contrari
major
infecti
agent
tse
agent
resist
physic
chemic
method
commonli
use
decontamin
infecti
agent
shown
neuroblastoma
cell
line
primari
cultur
neuron
astrocyt
serv
host
butler
et
al
although
mani
studi
suggest
risk
propag
tse
agent
tissu
cultur
cell
cultiv
presenc
bovin
serum
potenti
contamin
tse
restrict
neuron
brainderiv
cell
cultur
shown
recent
nonneuron
cell
also
support
tse
infect
suggest
cell
line
express
normal
host
prion
protein
could
potenti
support
propag
tse
agent
vilett
et
al
vorberg
et
al
understand
transmiss
prion
still
progress
natur
transmiss
seem
mainli
take
place
via
oral
rout
human
anim
investig
use
cell
cultur
need
take
account
differ
rout
agent
may
transmit
experiment
mous
scrapi
aerosol
transmiss
success
obtain
mice
haybaeck
et
al
cervid
chronic
wast
diseas
cwd
alreadi
propos
natur
airborn
pathogen
denker
et
al
case
creutzfeldt
jacob
diseas
cjd
date
proof
releas
prion
aerosol
anim
cell
cultur
also
harbour
unknown
pathogen
whose
tropism
defin
yet
exampl
describ
literatur
includ
virus
hepat
g
linnen
et
al
moor
et
al
tt
viru
nishizawa
et
al
human
pneumoviru
van
den
hoogen
et
al
cell
cultur
contamin
differ
sourc
infect
organ
infect
anim
cell
tissu
cell
line
establish
primari
sourc
contamin
accident
contamin
also
occur
materi
use
cell
cultur
includ
glasswar
storag
bottl
pipett
due
incorrect
mainten
sterilis
use
dispos
materi
lip
cultur
flask
outsid
use
pipett
import
sourc
contamin
mycoplasma
mcgarriti
nowaday
use
dispos
steril
pipett
significantli
decreas
likelihood
adventiti
contamin
third
sourc
contamin
resid
cultur
media
compon
serum
basic
cultur
media
salt
solut
enzym
trypsin
pronas
collagenas
exampl
media
addit
deriv
bovin
sourc
often
contamin
bovin
viral
diarrhoea
viru
bvdv
leve
wessman
mention
rel
resist
tse
agent
may
also
issu
use
bovinederiv
product
tissu
cultur
supplement
final
nonfilt
air
suppli
cloth
personnel
floor
sourc
airborn
contamin
hay
genet
modifi
gm
anim
cell
cultur
employ
number
differ
activ
exampl
express
transgen
product
protein
interest
whose
function
depend
methyl
sulfat
phosphoryl
lipid
addit
glycosyl
may
necessit
capac
higher
eukaryot
cell
perform
posttransl
modif
gm
anim
cell
cultur
may
also
chosen
replic
defect
recombin
even
wild
type
virus
risk
assess
gm
cell
follow
fivestep
methodolog
outlin
fig
mean
evalu
individu
aspect
process
genet
modif
perform
includ
evalu
recipi
cell
vector
donor
organ
properti
assess
characterist
insert
genet
materi
comprehens
risk
assess
genet
modifi
cell
express
transgen
also
take
account
risk
associ
transgen
product
gene
product
may
intrins
harm
eg
toxic
properti
could
induc
hazard
properti
via
express
gm
cell
depend
upon
genom
integr
site
promot
activ
express
regulatori
sequenc
govern
express
risk
assess
transgen
straightforward
demand
appropri
consider
comprehens
review
specif
address
topic
bergman
et
al
van
den
akker
et
al
genet
modif
may
confer
expand
lifespan
immortalis
increas
capac
tumour
induct
howev
unlik
recombin
properti
obtain
genet
modif
may
advers
effect
upon
releas
recombin
anim
human
cell
environ
cell
genet
modifi
difficulti
surviv
hostil
environ
control
temperatur
osmol
lack
cellspecif
nutrient
eg
glucos
vitamin
lipid
balanc
miss
henc
surviv
primari
cell
cell
line
outsid
proper
condit
unlik
occur
apart
fact
gm
cell
cultur
may
harbour
pathogen
pose
seriou
biolog
risk
human
health
discuss
recombin
cell
like
caus
harm
enter
bodi
anim
human
howev
extent
harm
effect
remain
hard
predict
kept
mind
lack
histocompat
recombin
cell
host
organ
remain
major
obstacl
cell
surviv
multipli
natur
immun
respons
healthi
immunocompet
host
recognis
foreign
cell
eventu
destroy
also
one
main
reason
cultur
cell
origin
laboratori
worker
allow
research
diagnost
activ
risk
associ
autolog
cell
particular
attent
paid
use
packag
cell
line
establish
cell
line
deliber
stabli
transfect
helper
construct
ensur
replic
packag
replic
defici
viral
vector
exampl
case
retrovir
packag
cell
line
express
helper
gene
allow
highlevel
constitut
product
viral
protein
eg
gag
pol
env
protein
miss
genom
replic
defici
viral
vector
crucial
viral
replic
one
main
biosafeti
issu
relat
use
packag
cell
line
fact
replicationcompet
virus
may
gener
result
homolog
recombin
replic
defici
viral
vector
viral
sequenc
present
packag
cell
event
could
result
format
virus
novel
yet
unwant
properti
gener
replicationcompet
virus
one
strategi
engin
safer
gener
packag
cell
line
consist
minimis
likelihood
gener
replicationcompet
virus
separ
viral
function
element
differ
express
plasmid
therebi
increas
number
recombin
event
necessari
gener
replicationcompet
virus
dull
et
al
reduc
elimin
sequenc
homolog
viral
vector
helper
sequenc
howev
endogen
retroviru
genom
express
safer
gener
retrovir
packag
cell
line
may
still
give
rise
unwant
recombin
event
chong
et
al
mean
possibl
gener
replicationcompet
virus
rule
clearli
risk
group
transfect
packag
cell
line
depend
risk
group
viral
vector
consequ
risk
assess
packag
cell
line
base
biosafeti
produc
viral
vector
includ
evalu
infect
spectrum
host
rang
capac
integr
insert
mutagenesi
stabil
physiolog
role
transgen
express
baldo
et
al
asid
identif
characteris
hazard
intrins
cell
cultur
thorough
risk
assess
must
also
consid
exposur
pathway
cell
cultur
may
present
risk
human
health
environ
necessit
evalu
type
manipul
process
method
andor
equip
involv
may
increas
decreas
likelihood
exposur
henc
result
potenti
risk
instanc
establish
cell
line
inher
present
low
risk
larg
scale
oper
involv
cultur
larg
volum
l
prone
contamin
inadequ
contain
measur
appli
exemplifi
continu
process
cell
cultiv
bioreactor
appropri
design
seal
valv
pump
transfer
line
requir
guarante
longterm
steril
oper
avoid
inadvert
contamin
opposit
handl
cell
cultur
belong
risk
group
may
present
less
risk
fix
glutaraldehyd
formaldehydeaceton
immunostain
may
therefor
requir
less
stringent
contain
measur
manipul
common
research
diagnost
activ
warrant
consider
respect
risk
assess
anim
cell
cultur
describ
hereund
procedur
gener
aerosol
pipet
vortex
centrifug
open
wet
cup
etc
handl
cell
outsid
class
ii
bsc
flow
cytometr
analysi
cell
sort
constitut
special
case
cell
manipul
cell
handl
outsid
bsc
use
fix
mani
case
appropri
eg
viabl
cell
sort
subsequ
cell
cultur
risk
aerosol
format
particularli
high
especi
sort
experi
upon
instrument
failur
clog
sort
nozzl
scientist
field
flow
cytometri
must
awar
potenti
hazard
associ
disciplin
experienc
welltrain
oper
perform
potenti
biohazard
cell
sort
gener
recommend
approv
intern
societi
analyt
cytolog
help
set
basi
biosafeti
guidelin
flow
cytometri
laboratori
schmid
standard
oper
procedur
method
also
describ
ensur
cell
sort
optim
biosafeti
condit
even
condit
lennartz
et
al
perfetto
et
al
alter
cultur
condit
chang
avail
cellspecif
nutrient
growth
factor
signal
molecul
adopt
cocultur
techniqu
may
signific
effect
anim
cell
cultur
may
result
alter
neoplasia
stoker
et
al
alter
express
proto
oncogen
cell
surfac
glycoprotein
releas
endogen
virus
cunningham
et
al
consequ
chang
cultur
condit
may
lead
alter
suscept
cultur
cell
biolog
agent
virus
ander
et
al
vincent
et
al
manipul
involv
use
needl
sharp
due
injuri
cell
materi
may
accident
transfer
directli
oper
tissu
andor
blood
stream
vivo
experi
involv
anim
major
risk
selfinocul
needlestick
injuri
exposur
aerosol
laboratori
worker
handl
infect
rodent
cell
cultur
origin
infect
anim
expos
risk
directli
expos
cut
open
wound
mucu
membran
infect
bodi
fluid
inhal
infecti
aerosol
particl
rodent
urin
faec
saliva
risk
minimis
utilis
anim
cell
cultur
sourc
regularli
test
viru
final
purpos
cell
cultur
taken
consider
mani
clinic
approach
stem
cell
therapi
gene
therapi
xenoor
allotransplant
involv
cell
cultur
ex
vivo
therapeut
purpos
latter
clearli
justifi
care
consider
regard
safeti
ethic
social
regulatori
issu
address
chapter
food
drug
administr
european
medicin
agenc
ich
assess
biolog
risk
relat
anim
cell
cultur
type
manipul
allow
determin
adequ
contain
level
order
optim
protect
human
health
environ
implement
appropri
contain
level
includ
list
gener
specif
work
practic
contain
measur
tabl
list
precautionari
measur
appli
whenev
handl
anim
cell
cultur
much
measur
focu
reduc
risk
contamin
adventiti
agent
emphasis
drawnup
appropri
set
standard
oper
procedur
adequ
train
staff
crucial
import
gener
rule
cell
cultur
known
harbour
infecti
etiolog
agent
manipul
complianc
contain
measur
recommend
etiolog
agent
cell
cultur
known
harbour
infecti
agent
cell
may
consid
free
contamin
pathogen
long
number
condit
fulfil
impli
use
wellcharacteris
cell
line
control
cell
sourc
primari
cell
specifiedpathogenfre
spf
anim
wellcharacteris
cell
line
spf
avail
test
detect
like
contamin
agent
neg
second
whenev
cell
cultur
manipul
media
sourc
pathogen
free
appropri
contain
measur
adopt
reduc
potenti
contamin
sampl
subsequ
manipul
cell
refeed
wash
step
histori
cell
cultur
may
poorli
document
given
cell
cultur
manipul
first
time
laboratori
often
remain
unclear
whether
appropri
measur
implement
regardless
fact
may
manipul
year
anoth
laboratori
facil
case
cell
cultur
consid
potenti
infecti
manipul
class
ii
bsc
presenc
adventiti
agent
higher
risk
group
consid
like
cell
line
handl
appropri
contain
level
test
proven
absenc
organ
good
document
histori
cell
cultiv
mandatori
extent
cell
cultur
control
likelihood
contamin
strongli
depend
natur
activ
exampl
guidelin
issu
aim
minimis
potenti
risk
transmiss
infecti
agent
respect
use
anim
cell
cultur
industri
product
biopharmaceut
european
medicin
agenc
food
drug
administr
ich
world
health
organ
hardli
guidanc
provid
extent
detect
possibl
contamin
case
anim
cell
cultur
use
vitro
research
diagnost
activ
purpos
therapeut
product
biopharmaceut
choic
detect
techniqu
depend
contamin
pathogen
often
combin
method
recommend
import
sampl
master
cell
bank
implement
measur
adequ
work
carri
cell
cultur
human
primat
origin
measur
may
consid
provid
manipul
occur
class
ii
bsc
cell
cultur
wellcharacteris
certifi
cell
line
present
increas
risk
result
genet
modif
contamin
pathogen
contain
use
complianc
good
cell
cultur
practic
gccp
especi
industri
set
vaccin
product
avoid
open
cultur
vessel
contact
cultur
fluid
defect
cultur
vessel
stopper
poor
techniqu
ever
present
likelihood
contamin
airborn
pathogen
treat
new
cultur
manipul
first
time
laboratori
facil
potenti
infecti
clean
cultur
fluid
spill
immedi
appropri
valid
disinfect
protocol
work
one
cell
line
time
disinfect
work
surfac
two
oper
involv
cell
line
aliquot
growth
medium
substrat
vessel
use
one
cell
line
mitig
crosscontamin
avoid
pour
action
proceed
use
biosafeti
cabinet
bsc
adequ
train
staff
ti
turn
period
use
thoroughli
disinfect
bsc
surfac
work
session
clutter
bsc
unnecessari
materi
restrict
use
antibiot
growth
media
quarantin
new
cell
cultur
dedic
bsc
separ
laboratori
cultur
shown
neg
appropri
test
carri
qualiti
control
cell
demonstr
absenc
like
contamin
pathogen
regular
basi
whenev
necessari
oper
cell
cultur
undefin
sourc
risk
groupclass
risk
organ
presenc
adventiti
agent
higher
risk
class
expect
cell
line
handl
appropri
contain
level
test
proven
safeti
adapt
pauwel
et
al
viral
infect
cell
could
envisag
viral
particl
detect
supernat
infect
cell
howev
emphas
procedur
viral
clearanc
virushost
specif
variabl
vector
titr
infect
protocol
influenc
degre
rate
clearanc
bagutti
et
al
sinc
implement
good
laboratori
practic
use
bsc
usual
norm
laboratori
deal
cell
cultur
think
laboratori
rel
easili
upgrad
facil
implement
restrict
number
simpl
addit
safeti
measur
import
notic
horizont
laminar
air
flow
clean
bench
minimis
risk
adventiti
contamin
cell
cultur
howev
offer
protect
manipul
environ
bear
mind
biosafeti
measur
intend
provid
maxim
protect
human
health
environ
import
note
sole
use
horizont
laminar
clean
bench
prohibit
base
limit
key
featur
risk
assess
type
manipul
perform
discuss
former
paragraph
develop
flow
diagram
provid
cell
cultur
user
schemat
guidanc
assign
appropri
contain
level
manipul
human
primat
cell
vitro
fig
flowchart
indic
appli
andor
reconsid
accord
case
specif
condit
risk
assess
proper
activ
perform
whenev
possibl
approach
develop
ab
initio
reduc
risk
associ
handl
anim
cell
cultur
favour
approach
involv
use
dedic
instrument
safer
biolog
materi
exampl
hereund
illustr
choic
appli
one
sever
approach
determin
casebycas
basi
depend
intrins
characterist
biolog
materi
intend
use
last
coupl
year
instrument
enabl
autom
mechan
passag
nutrient
suppli
vitro
cell
expans
develop
primari
cell
adher
nonadher
mammalian
cell
kato
et
al
thoma
ratcliff
develop
also
provid
safer
approach
respect
biosafeti
consider
includ
biosafeti
modul
design
autom
platform
exampl
longterm
cell
cultur
devic
ensur
protect
product
oper
design
cultur
embryon
stem
cell
antibioticfre
medium
mean
integr
autom
platform
use
class
ii
bsc
confin
microwel
liquid
handl
robot
contain
bsc
hussain
et
al
autom
system
also
deploy
product
ml
pseudoviru
hiv
vaccin
trial
complianc
gclp
robust
autom
system
cultiv
cell
contain
class
ii
bsc
guarante
protect
worker
environ
product
system
implement
produc
biolog
reagent
standardis
largescal
condit
schultz
et
al
lower
hazard
associ
cell
cultur
handl
anoth
approach
appli
characteris
pandem
influenza
virus
emerg
situat
activ
typic
requir
condit
inactiv
protocol
appli
influenza
viru
cultur
allow
perform
virolog
immunolog
assay
condit
jong
et
al
anoth
exampl
assign
less
stringent
contain
level
enabl
relat
use
insect
cell
gm
bacteriophag
lambda
capsid
case
usual
mainten
infecti
stock
highli
pathogen
emerg
influenza
virus
involv
domm
et
al
bacteriophag
decor
viral
glycoprotein
interest
insect
cellderiv
system
use
hemagglutinin
display
bacteriophag
hemagglutinationinhibit
assay
pathogen
influenza
virus
approach
alreadi
appli
hivenvelop
protein
mattiacio
et
al
regard
vitro
test
noninfecti
cellbas
assay
assess
suscept
proteas
inhibitor
also
develop
recent
buzon
et
al
activ
normal
requir
rel
high
contain
level
perform
facil
less
expens
infrastructur
also
show
care
consider
materi
handl
lead
costeffect
choic
maintain
object
biosafeti
intern
recogn
concept
refer
maxim
protect
laboratori
worker
public
health
environ
possibl
advers
effect
associ
use
organ
microorgan
genet
modifi
within
respect
activ
involv
use
anim
cell
cultur
fundament
research
r
vitro
diagnosi
purpos
pose
biosafeti
consider
well
start
activ
biosafeti
consider
address
perform
biolog
risk
assess
allow
identif
characteris
potenti
advers
effect
togeth
evalu
likelihood
consequ
effect
happen
approach
made
casebycas
basi
take
account
type
manipul
type
cell
cultur
handl
risk
assess
result
biosafeti
recommend
view
implement
adequ
contain
level
consid
limit
persist
capac
anim
human
cell
outsid
nonoptimis
cultur
condit
fact
mani
cell
line
long
histori
safe
use
gener
consid
unlik
cell
cultur
may
inher
caus
harm
human
environ
main
hazard
associ
handl
anim
cell
cultur
resid
presenc
adventiti
pathogen
microorgan
often
difficult
detect
henc
less
control
contrast
host
cell
adventiti
organ
persist
hostil
condit
may
present
risk
human
health
environ
case
pathogen
bean
et
al
walther
ewald
kallio
et
al
kramer
et
al
reason
risk
assess
cell
cultur
frequent
lead
risk
assess
potenti
adventiti
contamin
organ
use
cell
immortalis
virus
viral
sequenc
etc
andor
microorgan
intent
use
experiment
infect
though
assign
biosafeti
contain
level
requir
generalis
perform
casebycas
basi
recognis
contain
measur
primarili
aim
protect
cell
adventiti
contamin
order
mitig
potenti
risk
laboratori
worker
except
authent
cell
line
prove
present
risk
activ
involv
cell
cultur
human
primat
origin
gener
perform
contain
level
involv
use
class
ii
biosafeti
cabinet
good
laboratori
practic
whilst
occurr
advers
effect
relat
handl
cell
cultur
exclud
thorough
risk
assess
implement
appropri
contain
level
offer
optim
protect
laboratori
worker
extens
public
health
environ
continu
effort
made
mitig
risk
associ
handl
cell
cultur
laboratori
set
biorisk
manag
continu
measur
ie
adopt
appropri
contain
level
coupl
implement
autom
platform
allow
reduct
cell
cultur
crosscontamin
accident
contamin
infecti
agent
anticip
futur
effort
contribut
improv
qualiti
data
necessari
risk
assess
contain
measur
increas
awar
biosafeti
consider
within
scientif
commun
also
directli
benefit
qualiti
research
activ
involv
anim
cell
cultur
authent
process
true
origin
ident
cell
line
determin
form
essenti
part
cell
cultur
oper
biosafeti
context
chapter
biosafeti
relat
evalu
potenti
risk
human
health
environ
associ
use
genet
modifi
organ
gmo
pathogen
organ
biosafeti
cabinet
class
ii
safeti
cabinet
front
apertur
oper
carri
manipul
insid
cabinet
construct
laboratori
worker
protect
product
cross
contamin
low
escap
airborn
particul
contamin
gener
within
cabinet
control
mean
appropri
filter
intern
airflow
filtrat
exhaust
air
hepa
filter
contain
use
activ
micro
organ
genet
modifi
organ
pathogen
cultur
store
transport
destroy
dispos
use
way
specif
contain
measur
use
limit
contact
gener
popul
environ
cultur
type
primari
cell
cultur
diploid
cell
line
continu
cell
line
primari
cell
cultur
establish
directli
tissu
anim
often
appropri
vitro
tool
reproduc
typic
cellular
respons
observ
vivo
howev
typic
cell
characterist
lost
passag
cultur
must
obtain
fresh
tissu
may
contain
may
becom
inadvert
contamin
pathogen
consequ
primari
cell
cultur
may
potenti
present
increas
risk
compar
continu
establish
cell
line
diploid
cell
line
similar
primari
cell
consid
nontumourogen
finit
capac
serial
propag
use
prepar
viral
vaccin
human
monkey
origin
continu
cell
line
immort
cell
may
surviv
almost
infinit
serial
passag
cell
obtain
either
isol
cell
tumour
neoplast
origin
primari
cell
treat
mutagen
oncogen
virus
recombin
dna
oncogen
cell
fusion
primari
cell
continu
cell
line
consequ
class
risk
cell
line
often
correl
class
risk
primari
cell
deriv
due
immort
continu
cell
line
abil
induc
tumour
also
consid
transfect
gene
transfer
dna
eukaryot
cell
use
nonvir
deliveri
method
transduct
gene
transfer
dna
eukaryot
cell
use
viral
vector
infect
process
occur
viru
wild
type
typic
replic
spread
neighbour
cell
mediat
gene
transfer
belong
genom
extra
gene
may
carri
viral
vector
protein
particl
deriv
replic
viru
contain
genet
inform
form
rna
dna
viral
envelop
may
present
well
